Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510
- Piscoya, A.; Ng-Sueng, L.F.; Parra Del Riego, A.; Cerna-Viacava, R.; Pasupuleti, V.; Roman, Y.M.; Thota, P.; White, C.M.; Hernandez, A.V. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. PLoS ONE 2020, 15, e0243705.
- Guo, J.; Sheng, K.; Wu, S.; Chen, H.; Xu, W. An Update on the Relationship of SARS-CoV-2 and Male Reproduction. Front. Endocrinol. 2021, 12, 788321.
References
- Mukherjee, A.G.; Wanjari, U.R.; Gopalakrishnan, A.V.; Kannampuzha, S.; Murali, R.; Namachivayam, A.; Ganesan, R.; Renu, K.; Dey, A.; Vellingiri, B.; et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510. [Google Scholar] [CrossRef] [PubMed]
- Piscoya, A.; Ng-Sueng, L.F.; Parra Del Riego, A.; Cerna-Viacava, R.; Pasupuleti, V.; Roman, Y.M.; Thota, P.; White, C.M.; Hernandez, A.V. Efficacy and harms of remdesivir for the treatment of COVID-19: A systematic review and meta-analysis. PLoS ONE 2020, 15, e0243705. [Google Scholar] [CrossRef] [PubMed]
- Guo, J.; Sheng, K.; Wu, S.; Chen, H.; Xu, W. An Update on the Relationship of SARS-CoV-2 and Male Reproduction. Front. Endocrinol. 2021, 12, 788321. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Mukherjee, A.G.; Wanjari, U.R.; Gopalakrishnan, A.V.; Kannampuzha, S.; Murali, R.; Namachivayam, A.; Ganesan, R.; Renu, K.; Dey, A.; Vellingiri, B.; et al. Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510. Vaccines 2024, 12, 996. https://doi.org/10.3390/vaccines12090996
Mukherjee AG, Wanjari UR, Gopalakrishnan AV, Kannampuzha S, Murali R, Namachivayam A, Ganesan R, Renu K, Dey A, Vellingiri B, et al. Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510. Vaccines. 2024; 12(9):996. https://doi.org/10.3390/vaccines12090996
Chicago/Turabian StyleMukherjee, Anirban Goutam, Uddesh Ramesh Wanjari, Abilash Valsala Gopalakrishnan, Sandra Kannampuzha, Reshma Murali, Arunraj Namachivayam, Raja Ganesan, Kaviyarasi Renu, Abhijit Dey, Balachandar Vellingiri, and et al. 2024. "Correction: Mukherjee et al. Insights into the Scenario of SARS-CoV-2 Infection in Male Reproductive Toxicity. Vaccines 2023, 11, 510" Vaccines 12, no. 9: 996. https://doi.org/10.3390/vaccines12090996